GlaxoSmithKline Digital Transformation Analysis Report 2024: Accelerators, Incubators, and Innovation Programs - ResearchAndMarkets.com

The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering.

The report provides insights into company's tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.

GSK plc (GSK) is a healthcare company that focuses on developing, manufacturing and commercializing general medicines, specialty medicines and vaccines. It offers drugs for the treatment of diseases such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, and urogenital, anti-bacterial, dermatology and rare diseases.

The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastrointestinal diseases. GSK's vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide.

The report provides information and insights into GSK's tech activities, including:

• Insights of its digital transformation strategies and innovation programs.
• Overview of technology initiatives covering partnerships, product launches and acquisitions.
• Insights on each technology initiative including technology theme, objective, and benefits.
• Details of estimated ICT budgets and major ICT contracts.

Reasons to Buy

• Gain insights into GSK's tech operations.
• Gain insights into its tech strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into various product launches, partnerships and acquisitions.

Key Topics Covered:

• Overview
• Digital Transformation Strategy
• Accelerators, Incubators, and Innovation Programs
• Technology Focus
• Technology Initiatives
• Acquisitions
• Partnership, and Acquisition Network Map
• ICT Budget
• Key Executives

A selection of companies mentioned in this report includes, but is not limited to:

• Cerebras Systems
• Tempus
• Progentec
• Viome
• InveniAI
• Nvidia
• Cloud Pharmaceuticals
• 23andMe
• Cytel
• Microsoft
• Alibaba Group
• Elsie Biotechnologies

For more information about this company profile visit https://www.researchandmarkets.com/r/a2ycq8

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250311958978/en/